← Back to Search

PREPARED Trial Intervention for Dementia (PREPARED Trial)

N/A
Waitlist Available
Led By Machelle Wilchesky, PhD
Research Sponsored by McGill University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up over the study period (18 weeks)
Awards & highlights

PREPARED Trial Summary

This study is evaluating whether a set of activities can reduce the number of new cases of delirium in people with dementia.

Eligible Conditions
  • Dementia
  • Delirium

PREPARED Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~over the study period (18 weeks)
This trial's timeline: 3 weeks for screening, Varies for treatment, and over the study period (18 weeks) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Delirium episode duration
Delirium severity
Incidence of delirium
+1 more
Secondary outcome measures
Change in cognitive functioning
Change in functional autonomy
Change in level of social engagement
+3 more

PREPARED Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: PREPARED Trial InterventionExperimental Treatment1 Intervention
Participating nursing staff will be trained to apply the PREPARED Trial interventions, and will apply this knowledge to modify the therapeutic nursing plans of residents under their care who are enrolled in the study, accordingly.
Group II: Care as UsualActive Control1 Intervention
Participating nursing staff will only be provided with general information about delirium, but will not be trained or instructed to modify the therapeutic nursing plans that are in place for residents enrolled in the study. However, at the end of the follow-up period, nursing staff in the control arm will be provided with the PREPARED Trial intervention training program (including bedside coaching), which they can then use after the study has ended at their facility.

Find a Location

Who is running the clinical trial?

McGill UniversityLead Sponsor
394 Previous Clinical Trials
997,581 Total Patients Enrolled
6 Trials studying Dementia
3,389 Patients Enrolled for Dementia
T.T. Minh Vu, MD, FRCPCStudy ChairCentre hospitalier de l'Université de Montréal (CHUM)
Ovidiu Lungu, PhDStudy ChairUniversité de Montréal

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Annals of Internal MedicineJournal
Clarifying Confusion: The Confusion Assessment Method
Inouye, Sharon K.. 1990. “Clarifying Confusion: The Confusion Assessment Method”. Annals of Internal Medicine. American College of Physicians. doi:10.7326/0003-4819-113-12-941.
clinicaltrials.govStudy
The Prevention Program for Alzheimer's Related Delirium (PREPARED) Trial
Machelle Wilchesky 2018. "The Prevention Program for Alzheimer's Related Delirium (PREPARED) Trial". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03718156.
~125 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top